Acta Oncologica, Volume 49, Issue 1 (2010)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Acta Oncologica, Volume 49, Issue 1 (2010)

See all volumes and issues
Vol 62, 2023 Vol 61, 2022 Vol 60, 2021 Vol 59, 2020 Vol 58, 2019 Vol 57, 2018 Vol 56, 2017 Vol 55, 2016 Vol 54, 2015 Vol 53, 2014 Vol 52, 2013 Vol 51, 2012 Vol 50, 2011 Volume 49, 2010 Vol 48, 2009 Vol 47, 2008 Vol 46, 2007 Vol 45, 2006 Vol 44, 2005 Vol 43, 2004 Vol 42, 2003 Vol 41, 2002 Vol 40, 2001 Vol 39, 2000 Vol 38, 1999 Vol 37, 1998 Vol 36, 1997 Vol 35, 1996 Vol 34, 1995 Vol 33, 1994 Vol 32, 1993 Vol 31, 1992 Vol 30, 1991 Vol 29, 1990 Vol 28, 1989 Vol 27, 1988 Vol 26, 1987 Vol 25, 1986 Vol 24, 1985 Vol 23, 1984 Vol 22, 1983 Vol 21, 1982 Vol 20, 1981 Vol 19, 1980 Vol 18, 1979 Vol 17, 1978 Vol 16, 1977 Vol 15, 1976 Vol 14, 1975 Vol 13, 1974 Vol 12, 1973 Vol 11, 1972 Vol 10, 1971 Vol 9, 1970 Vol 8, 1969 Vol 7, 1968 Vol 6, 1967 Vol 5, 1966 Vol 4, 1966 Vol 3, 1965 Vol 2, 1964 Vol 1, 1963
Download citations Download PDFs Download issue

REVIEW ARTICLE

Review Article
A systematic review and meta-analysis of immunochemotherapy with rituximab for B-cell non-Hodgkin's lymphoma
Guanghui Gao, Xiaohua Liang, Jingwei Jiang, Xinli Zhou, Ruofan Huang, Zhaohui Chu & Qiong Zhan
Pages: 3-12
Published online: 26 Jan 2010
AbstractforA systematic review and meta-analysis of immunochemotherapy with rituximab for B-cell non-Hodgkin's lymphoma | Full Text | References | PDF (4.4 MB)
  • 3624 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Targeted therapies in the treatment of GIST: Adverse events and maximising the benefits of sunitinib through proactive therapy management
Pascal Wolter & Patrick Schöffski
Pages: 13-23
Published online: 10 Nov 2009
AbstractforTargeted therapies in the treatment of GIST: Adverse events and maximising the benefits of sunitinib through proactive therapy management | Full Text | References | PDF (79 KB)
  • 1238 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

ORIGINAL ARTICLE

Article
Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)
Oscar Matzinger, Irma Heimsoth, Philip Poortmans, Laurence Collette, Henk Struikmans, Walter Van Den Bogaert, Alain Fourquet, Harry Bartelink, Fatma Ataman, Akos Gulyban, Marianne Pierart, Geertjan Van Tienhoven, For The Eortc Radiation Oncology & Breast Cancer Groups
Pages: 24-34
Published online: 26 Jan 2010
AbstractforToxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925) | Full Text | References | PDF (79.9 KB)
  • 4173 Views
  • 87 CrossRef citations
  • 0Altmetric
Free Access
Article
Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study
Annika Malmström, Jörgen Hansen, Lena Malmberg, Lena Carlsson, Jan-Henry Svensson, Johan Ahlgren, Cecila Ahlin, Tomas Jansson & Ronny Westberg
Pages: 35-41
Published online: 20 Oct 2009
AbstractforGemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study | Full Text | References | PDF (68.8 KB)
  • 986 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
Preoperative radiotherapy in rectal signet-ring cell carcinoma – magnetic resonance imaging and treatment outcome
Åse Bratland, Turid Vetrhus, Krystyna Grøholt & Anne Hansen Ree
Pages: 42-49
Published online: 26 Jan 2010
AbstractforPreoperative radiotherapy in rectal signet-ring cell carcinoma – magnetic resonance imaging and treatment outcome | Full Text | References | PDF (14.2 MB)
  • 1746 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access
Article
Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet
Pasquale Comella, Rossana Casaretti, Raffaella Manzo, Claudia Sandomenico, Marina Licenziato, Antonio Avallone, Luca Franco & ON BEHALF OF THE SOUTHERN ITALY COOPERATIVE ONCOLOGY GROUP INVESTIGATORS
Pages: 50-56
Published online: 26 Jan 2010
AbstractforBaseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet | Full Text | References | PDF (207.6 KB)
  • 949 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer
Kristoffer Derwinger, Karl Kodeda, Elinor Bexe-Lindskog & Helena Taflin
Pages: 57-62
Published online: 10 Dec 2009
AbstractforTumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer | Full Text | References | PDF (2.2 MB)
  • 4614 Views
  • 58 CrossRef citations
  • 0Altmetric
Free Access
Article
A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer
Irina Corin, Lisa Larsson, Jörgen Bergström, Bengt Gustavsson & Kristoffer Derwinger
Pages: 63-69
Published online: 10 Dec 2009
AbstractforA study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer | Full Text | References | PDF (658.9 KB)
  • 758 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access
Article
SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation
Kamal Yavari, Mohammad Taghikhani, Mohammad Ghannadi Maragheh, Seyed A. Mesbah-Namin, Mohammad Hosein Babaei, Ali Jabbary Arfaee, Hossein Madani & Hamid Reza Mirzaei
Pages: 70-75
Published online: 10 Dec 2009
AbstractforSiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation | Full Text | References | PDF (182 KB)
  • 1662 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access
Article
Separation and identification of differentially expressed nuclear matrix proteins in breast carcinoma forming
Qian He, Shu-Qun Zhang, Yong-Lie Chu, Xiao-Li Jia, Li-Hua Zhao & Xiang-Ling Wang
Pages: 76-84
Published online: 02 Nov 2009
AbstractforSeparation and identification of differentially expressed nuclear matrix proteins in breast carcinoma forming | Full Text | References | PDF (6.7 MB)
  • 848 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Matrix metalloproteinase (MMP)-7 in salivary gland cancer
Heikki Luukkaa, Pekka Klemi, Pirkko Hirsimäki, Tero Vahlberg, Atte Kivisaari, Veli-Matti Kähäri & Reidar Grénman
Pages: 85-90
Published online: 24 Nov 2009
AbstractforMatrix metalloproteinase (MMP)-7 in salivary gland cancer | Full Text | References | PDF (2.7 MB)
  • 1050 Views
  • 28 CrossRef citations
  • 0Altmetric
Free Access
Article
An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer
Suyang Zhong, Debin Yu, Yigang Wang, Songbo Qiu, Songjie Wu & Xin Yuan Liu
Pages: 91-99
Published online: 26 Jan 2010
AbstractforAn armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer | Full Text | References | PDF (8 MB)
  • 1436 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access

LETTER TO THE EDITOR

Letter
Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®)
Henrik Kindmark, Eva Tiensuu Janson, Bengt Gustavsson, Camilla Eriksson, Gunnel Larsson, Dan Granberg, Gordana Kozlowacki, Britt Skogseid, Staffan Welin, Kjell Öberg & Barbro Eriksson
Pages: 100-101
Published online: 26 Jan 2010
CitationforFive patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®) | Full Text | References | PDF (79 KB)
  • 631 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Letter
Metastatic adamantinoma responds to treatment with receptor tyrosine kinase inhibitor
Arkadiusz Z. Dudek, Pradeep K. Murthaiah, Michael Franklin & Alexander M. Truskinovsky
Pages: 102-104
Published online: 26 Jan 2010
First Page PreviewforMetastatic adamantinoma responds to treatment with receptor tyrosine kinase inhibitor | Full Text | References | PDF (1.4 MB)
  • 1357 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Letter
Sorafenib induces partial response in metastatic medullary thyroid carcinoma
Elena Spector, Michael J. Franklin, Alexander M. Truskinovsky & Arkadiusz Z. Dudek
Pages: 105-107
Published online: 26 Jan 2010
First Page PreviewforSorafenib induces partial response in metastatic medullary thyroid carcinoma | Full Text | References | PDF (1.3 MB)
  • 796 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

ORIGINAL ARTICLE

Article
Lingual angioedema associated with everolimus
Morgan Mackenzie & Lori A. Wood
Pages: 108-110
Published online: 26 Jan 2010
First Page PreviewforLingual angioedema associated with everolimus | Full Text | References | PDF (92.5 KB)
  • 1320 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

LETTER TO THE EDITOR

Letter
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias
Fabio Stagno, Paolo Vigneri, Vittorio Del Fabro, Stefania Stella, Nunzio Restuccia, Cesarina Giallongo, Michele Massimino, Salvatore Berretta, Maria Stella Pennisi, Daniele Tibullo, Elena Tirrò, Calogero Buscarino, Angelo Messina & Francesco Di Raimondo
Pages: 111-112
Published online: 20 Oct 2009
CitationforConcomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias | Full Text | References | PDF (59.2 KB)
  • 865 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Letter
Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours
Ingrid M. E. Desar, H. Jorn Bovenschen, Anja J. N. H. Timmer-Bonte, Mireille V. Cantarini, Winette T. A. van der Graaf, Michelle M. van Rossum & Carla M. L. van Herpen
Pages: 113-116
Published online: 26 Jan 2010
First Page PreviewforCase studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours | Full Text | References | PDF (1 MB)
  • 742 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access
Letter
Primary extraosseous osteosarcoma of the lung
Elias A. Karfis, Theodoros Karaiskos, Angeliki Cheva & Georgios E. Drossos
Pages: 117-119
Published online: 26 Jan 2010
First Page PreviewforPrimary extraosseous osteosarcoma of the lung | Full Text | References | PDF (812 KB)
  • 933 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Letter
Oncolytic adenovirus treatment of a patient with refractory neuroblastoma
Sari Pesonen, Heikki Helin, Petri Nokisalmi, Sophie Escutenaire, Camilla Ribacka, Merja Sarkioja, Vincenzo Cerullo, Kilian Guse, Gerd Bauerschmitz, Leena Laasonen, Teemu Kantola, Ari Ristimaki, Maria Rajecki, Minna Oksanen, Elina Haavisto, Anna Kanerva, Timo Joensuu & Akseli Hemminki
Pages: 120-122
Published online: 26 Jan 2010
First Page PreviewforOncolytic adenovirus treatment of a patient with refractory neuroblastoma | Full Text | References | PDF (1.1 MB)
  • 809 Views
  • 26 CrossRef citations
  • 0Altmetric
Free Access

Research Article

Article
A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma
C Catania, G Pelosi, N Fazio, R Biffi, G Spitaleri, C Noberasco, MG Zampino, A Maggioni, G Trifirò, F Toffalorio, P Della Vigna, F De Braud & T De Pas
Pages: 123-124
Published online: 26 Jan 2010
CitationforA FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma | Full Text | References | PDF (345.1 KB)
  • 870 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

LETTER TO THE EDITOR

Letter
Chemotherapy maintenance: An option for prolonged survival in malignant peritoneal mesothelioma?
Silvia Hofer, Bernd Sasse & Hans Scheffel
Pages: 125-127
Published online: 02 Nov 2009
First Page PreviewforChemotherapy maintenance: An option for prolonged survival in malignant peritoneal mesothelioma? | Full Text | References | PDF (2.5 MB)
  • 634 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Letter
Somatic mutation of PIK3R1 gene is rare in common human cancers
Sang Wook Park, Mi Ran Kang, Hyeon Seok Eom, Ji Youn Han, Chang Hyeok Ahn, Sung Soo Kim, Sug Hyung Lee & Nam Jin Yoo
Pages: 128-130
Published online: 26 Jan 2010
First Page PreviewforSomatic mutation of PIK3R1 gene is rare in common human cancers | Full Text | References | PDF (110.9 KB)
  • 1557 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Letter
Sarcomatoid squamous cell carcinoma of the penis
Karol Axcrona, Bjørn Brennhovd, Morten Andersen & Aasmund Berner
Pages: 131-133
Published online: 26 Jan 2010
First Page PreviewforSarcomatoid squamous cell carcinoma of the penis | Full Text | References | PDF (1.3 MB)
  • 903 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Explore articles